Alpha interferon treatment in atopic dermatitis.
DOI:
https://doi.org/10.2340/0001555573130132Abstract
Eight patients suffering from atopic dermatitis were treated with interferon alpha 2b. They received low or intermediate doses (9/15 x 10(6) U/week) for a short period of time (4/8 weeks), with a moderate improvement of skin lesions in 4 of them and no change or an exacerbation of the disease in the other 4. Among the 4 patients who slightly improved at 4 weeks, 3 did not show any beneficial effect of interferon after 8 weeks. Serum IgE levels, which were increased in all patients before treatment, were not reduced under interferon therapy. This study shows that intermediate doses of interferon alpha 2b are not effective in the short/term treatment of atopic dermatitis.Downloads
Download data is not yet available.
Downloads
Published
1993-04-01
How to Cite
Jullien, D., Nicolas, J. F., Frappaz, A., & Thivolet, J. (1993). Alpha interferon treatment in atopic dermatitis. Acta Dermato-Venereologica, 73(2), 130–132. https://doi.org/10.2340/0001555573130132
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
